官方服务：
资源简介：
Molecular characterization of patient-derived xenograft models to accelarate tumor research and drug discovery.
应用场景：
创建时间：
2022-01-26
相关数据集
Connectivity Mapping-based Identification and Pre-clinical Evaluation of ISOX: A Novel Therapeutic for Pancreatic Cancer. Connectivity Mapping-based Identification and Pre-clinical Evaluation of ISOX: A Novel Therapeutic for Pancreatic Cancer
Pancreatic Cancer (PC) remains highly lethal due to limited therapeutic options. Here we utilize a genomic-data-driven Connectivity Mapping (CMAP) to identify a drug closer to real-world PC targeting.
NIAID Data Ecosystem40
Additional file 2 of Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer
Additional file 2.
NIAID Data Ecosystem30
Predicted candidate drugs for treating pancreatic cancer.
Predicted candidate drugs for treating pancreatic cancer.
NIAID Data Ecosystem20
Discovery of a Highly Potent and Orally Bioavailable STAT3 Dual Phosphorylation Inhibitor for Pancreatic Cancer Treatment
Increasing evidence has demonstrated that STAT3 phosphorylation at Tyr705 and Ser727 is closely associated with the progression and poor prognosis of pancreatic cancer. Herein, we report the function-
NIAID Data Ecosystem30
Identification, Structure–Activity Relationships of Marine-Derived Indolocarbazoles, and a Dual PKCθ/δ Inhibitor with Potent Antipancreatic Cancer Efficacy
Protein kinases C (PKCs) are a family of serine/threonine kinases involved in various cellular processes, including proliferation, differentiation, cell survival, and apoptosis. Here, we report the id
NIAID Data Ecosystem30
